Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Douwes (Wellington, New Zealand). Epidemiology of eosinophilic and noneosinophilic asthma. Annual Congress 2007 - Inflammatory phenotypes in airway disease

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Classification of noneosinophilic asthma Source: Annual Congress 2004 - Noneosinophilic asthma Year: 2004 Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022 Pulmonary hypertension in eosinophilic versus noneosinophilic COPD Source: ERJ Open Res, 7 (1) 00772-2020; 10.1183/23120541.00772-2020 Year: 2021 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Eosinophilic inflammation and asthma control Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Airway remodelling and TGFβ signalling in children with eosinophilic and non-eosinophilic asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Pathophysiology of non-eosinophilic severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Risk of bronchiectasis in bronchial asthma: steroid-dependent versus non-steroid-dependent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005 Benralizumab for severe asthma associated with extra-airway eosinophilic diseases Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Gender differences in eosinophilic airway inflammation in allergic and non-allergic asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Clinical features of eosinophilic COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015